Funded Grants

Back to results

The interplay of DNA regulatory elements and epigenetics in Alzheimer’s disease

Project Overview

Alzheimer’s disease (AD) is a severely disabling illness with biological causes that are not well understood. Abnormalities in gene function impacts brain activities and could cause AD. Enhancers are elements in the DNA code that enable the complex expression of genes. Epigenetic marks control enhancers, which in turn creates specific patterns of gene expression in cells. We will test whether abnormal control of enhancers is involved in AD. Dr. Labrie and her team will complete the most detailed analysis to date of epigenetic marks at enhancers throughout the genome. They will examine specific brain areas and cell types, which is important for accurate and sensitive detection. By using sophisticated DNA mapping approaches, they will identify disease-associated enhancers and the genes they affect. This project will provide a greater understanding of the biological origin of AD. By uncovering new disease pathways, this research will create avenues for the development of improved AD treatments.

Principal Investigator

Viviane Labrie , Centre for Addiction and Mental Health

Partners and Donors

Alzheimer Society of Canada

Project Complete

The interplay of DNA regulatory elements and epigenetics in Alzheimer’s disease

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodevelopment

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Society Research Program (ASRP)/Brain Canada New Investigator & Career Change Grants

  • Province

    Ontario

  • Start Date

    2015

  • Total Grant Amount

    $224,040

  • Health Canada Contribution

    $112,020